• Lōkahi Therapeutics, a GlucoTrack unit, introduced Qare, a real-time comparative health platform focused on GLP-1 medications.
• Public availability is scheduled to begin on Oct. 14, 2026, following an initial introduction timed to National GLP-1 Day.
• Platform targets cohort-based comparisons of patient-reported treatment outcomes across GLP-1 drugs, extending beyond standalone tracking tools.
• Lōkahi expects to expand Qare into additional therapeutic categories in later releases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GlucoTrack Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260930351610) on September 30, 2026, and is solely responsible for the information contained therein.